Cresset Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15.9M | Buy |
201,891
+2,265
| +1% | +$183K | 0.06% | 197 |
|
|
2026
Q1 | $17.4M | Buy |
199,626
+24,747
| +14% | +$2.37M | 0.08% | 174 |
|
|
2025
Q4 | $16.9M | Buy |
174,879
+7,991
| +5% | +$776K | 0.07% | 171 |
|
|
2025
Q3 | $16M | Buy |
166,888
+13,780
| +9% | +$1.27M | 0.07% | 169 |
|
|
2025
Q2 | $13.5M | Sell |
153,108
-42,383
| -22% | -$3.59M | 0.07% | 176 |
|
|
2025
Q1 | $17.7M | Sell |
195,491
-16,445
| -8% | -$1.47M | 0.09% | 146 |
|
|
2024
Q4 | $17M | Sell |
211,936
-123,693
| -37% | -$10.7M | 0.08% | 151 |
|
|
2024
Q3 | $30.4M | Buy |
335,629
+32,618
| +11% | +$2.74M | 0.12% | 117 |
|
|
2024
Q2 | $24M | Buy |
303,011
+28,818
| +11% | +$2.36M | 0.1% | 136 |
|
|
2024
Q1 | $24.1M | Buy |
274,193
+65,836
| +32% | +$5.62M | 0.12% | 113 |
|
|
2023
Q4 | $17.3M | Buy |
208,357
+8,741
| +4% | +$666K | 0.1% | 136 |
|
|
2023
Q3 | $15.8M | Sell |
199,616
-21,894
| -10% | -$1.83M | 0.06% | 150 |
|
|
2023
Q2 | $19.6M | Buy |
221,510
+203,328
| +1,118% | +$17.5M | 0.02% | 181 |
|
|
2023
Q1 | $1.47M | Sell |
18,182
-3,495
| -16% | -$285K | 0.03% | 271 |
|
|
2022
Q4 | $1.02M | Sell |
21,677
-3,144
| -13% | -$255K | 0.01% | 296 |
|
|
2022
Q3 | $2.02M | Sell |
24,821
-2,668
| -10% | -$240K | 0.03% | 211 |
|
|
2022
Q2 | $2.31M | Sell |
27,489
-3,787
| -12% | -$384K | 0.03% | 206 |
|
|
2022
Q1 | $3.49M | Sell |
31,276
-14,254
| -31% | -$1.51M | 0.04% | 168 |
|
|
2021
Q4 | $4.73M | Buy |
45,530
+3,514
| +8% | +$407K | 0.05% | 147 |
|
|
2021
Q3 | $5.29M | Buy |
42,016
+6,353
| +18% | +$822K | 0.07% | 108 |
|
|
2021
Q2 | $4.45M | Buy |
35,663
+2,760
| +8% | +$347K | 0.06% | 118 |
|
|
2021
Q1 | $3.9M | Buy |
32,903
+11,983
| +57% | +$1.4M | 0.06% | 110 |
|
|
2020
Q4 | $2.46M | Buy |
20,920
+1,122
| +6% | +$124K | 0.04% | 133 |
|
|
2020
Q3 | $2.07M | Buy |
19,798
+1,509
| +8% | +$152K | 0.04% | 159 |
|
|
2020
Q2 | $1.69M | Buy |
18,289
+3,137
| +21% | +$301K | 0.04% | 165 |
|
|
2020
Q1 | $1.37M | Buy |
15,152
+3,355
| +28% | +$357K | 0.04% | 151 |
|
|
2019
Q4 | $1.34M | Buy |
11,797
+1,948
| +20% | +$214K | 0.04% | 172 |
|
|
2019
Q3 | $1.07M | Sell |
9,849
-92
| -0.9% | -$9.6K | 0.03% | 180 |
|
|
2019
Q2 | $968K | Buy |
9,941
+392
| +4% | +$35.8K | 0.03% | 178 |
|
|
2019
Q1 | $875K | Buy |
9,549
+2,398
| +34% | +$215K | 0.03% | 123 |
|
|
2018
Q4 | $654K | Buy |
+7,151
| New | +$668K | 0.04% | 103 |
|
Other funds holding MDT
Cresset Asset Management's MDT Position: Q2 2026 in Review
Cresset Asset Management increased its Medtronic (MDT) stake by 1.1% in Q2 2026, buying an estimated $183K and bringing the position to 201,891 shares worth $15.9M. The position accounts for 0.06% of the portfolio, ranked #197.
Cresset Asset Management first reported a position in MDT in Q4 2018 and has held it in 31 quarters since. The position peaked at $30.4M in Q3 2024. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Cresset Asset Management held 201,891 shares of Medtronic worth $15.9M as of Q2 2026.
- Cresset Asset Management bought 2,265 Medtronic shares in Q2 2026, an estimated $183K.
- Medtronic made up 0.06% of Cresset Asset Management's portfolio in Q2 2026, its #197 holding.
- Cresset Asset Management first reported a position in Medtronic in Q4 2018 and has held it in 31 quarters since.
- Cresset Asset Management's Medtronic position peaked at $30.4M in Q3 2024.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Cresset Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.